US2008166772A1PendingUtilityA1

Methods of increasing the concentration of a nucleic acid

Assignee: HOLLINGER PHILLIPPriority: Sep 13, 2000Filed: Feb 15, 2008Published: Jul 10, 2008
Est. expirySep 13, 2020(expired)· nominal 20-yr term from priority
C12N 15/1075C12Q 1/6867C12N 9/1252C12N 15/1058C07K 2319/00
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

We describe a method of selecting an enzyme having replicase activity, the method comprising the steps of: (a) providing a pool of nucleic acids comprising members each encoding a replicase or a variant of the replicase; (b) subdividing the pool of nucleic acids into compartments, such that each compartment comprises a nucleic acid member of the pool together with the replicase or variant encoded by the nucleic acid member; (c) allowing nucleic acid replication to occur; and (d) detecting amplification of the nucleic acid member by the replicase. Methods for selecting agents capable of modulating replicase activity, and for selecting interacting polypeptides are also disclosed.

Claims

exact text as granted — not AI-modified
1 . (canceled) 
     
     
         2 . A method for increasing concentration of a nucleic acid molecule comprising the steps of:
 (a) forming microcapsules from a thermostable water-in-oil emulsion, wherein a plurality of microcapsules include a nucleic acid molecule, a bead capable of being linked to the nucleic acid molecule, and an aqueous solution comprising components necessary to perform PCR nucleic acid amplification, including a thermostable polymerase, wherein the emulsion has a density of greater than 10 9  microcapsules per ml;   (b) amplifying the nucleic acid molecule in the microcapsules to form amplified copies of the nucleic acid molecule; thereby increasing the concentration of the nucleic acid molecule; and   (c) sorting the bead with the captured amplification copies for sequencing.   
     
     
         3 . The method of  claim 2  wherein the amplified copies are captured to the beads in the microcapsules. 
     
     
         4 . The method of  claim 2  wherein the nucleic acid amplification is performed using a method selected from the group consisting of ligase chain reaction, self sustained sequence replication, reverse transcriptase-polymerase chain reaction, nucleic acid sequence-based amplification, and strand displacement amplification. 
     
     
         5 . The method of  claim 2  wherein the nucleic acid amplification is performed using polymerase chain reaction. 
     
     
         6 . The method of  claim 2  wherein the water-in-oil emulsion includes an emulsion stabilizer. 
     
     
         7 . The method of  claim 6  wherein the emulsion stabilizer is a non-ionic surfactant. 
     
     
         8 . The method of  claim 7  wherein the emulsion stabilizer is selected from the group consisting of sorbitan monooleate, polyoxyethylenesorbitan monooleate, and octylphenoxypolyethoxyethanol. 
     
     
         9 . The method of  claim 8  wherein the emulsion stabilizer is selected from the group consisting of Span80, Tween80, and TritonX-100. 
     
     
         10 . The method of  claim 6  wherein the emulsion stabilizer is an anionic surfactant. 
     
     
         11 . The method of  claim 10  wherein the emulsion stabilizer is selected from the group consisting of sodium cholate, sodium taurocholate, and sodium deoxycholate. 
     
     
         12 . The method of  claim 2  wherein the nucleic acid molecule is genomic DNA or cDNA. 
     
     
         13 . The method of  claim 2  wherein the nucleic acid molecule comprises a biotin tag. 
     
     
         14 . The method of  claim 2  wherein the bead comprises a coating of streptavidin or oligonucleotides. 
     
     
         15 . The method of  claim 2  wherein the bead is selected from the group consisting of polystyrene and magnetic beads. 
     
     
         16 . The method of  claim 2  wherein the water-in-oil phase ratio is between 1:2 and 1:4. 
     
     
         17 . The method of  claim 2  wherein a plurality of microcapsules when formed each contains on average one or less than one nucleic acid molecule. 
     
     
         18 . The method of  claim 2  wherein a plurality of microcapsules when formed each contains on average between 5 and 1000 nucleic acid molecules. 
     
     
         19 . The method of  claim 2  wherein the emulsion is stable for 20 cycles of PCR. 
     
     
         20 . The method of  claim 2  wherein the nucleic acid is delivered to the microcapsule by delivering a cell containing the nucleic acid to the microcapsule.

Join the waitlist — get patent alerts

Track US2008166772A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.